The detection of Philadelphia chromosome negative metaphases in long-term bone marrow cultures of the peripheral blood from patients with chronic myeloid leukemia predicts response to interferon-alpha 2a

S. Gronthos, L. B. To, S. Moore, J. M. Suttle, C. A. Juttner

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Abstract

The cytogenetic response of 10 patients with chronic myeloid leukaemia (CML) to human recombinant interferon-alpha 2a (rhlFNα 2a) was compared to the Philadelphia chromosome (Ph) status of the pre-treatment peripheral blood cells after in vitro culture under long-term bone marrow culture (LTBMC) conditions. Pre-treatment light density peripheral blood cells were cultured in LTBMC on sex-mismatched irradiated allogeneic stromal layers with weekly cytogenetic examination of metaphases in the nonadherent cell fraction. This was correlated with the patients' response to rhlFNα. Two groups of patients, five showing a cytogenetic response (responsive) and five who failed to achieve a cytogenetic response (nonresponsive) were studied. At the initiation of the LTBMCs the Ph′ was found to be present in 100% of the cells analysed for nine patients and 97% for one patient. Pretreatment peripheral blood from four responsive patients demonstrated a decline in the proportion of Ph′-positive cells (Ph+) after 1 to 2 weeks in LTBMC. In contrast, peripheral blood from all the nonresponsive subjects showed persistence of the Ph+ clone in 100% of the cells analysed out to a maximum of 3 to 5 weeks in LTBMC. A significant difference was observed (Fisher exact test, p = 0.023) between the two patient groups in respect to the appearance of normal clones in the nonadherent population. The presence of Ph- metaphases in LTBMC of peripheral blood cells of CML patients may predict their cytogenetic response to rhlFNα 2a.

Original languageEnglish
Pages (from-to)1246-1249
Number of pages4
JournalLeukemia
Volume6
Issue number12
Publication statusPublished or Issued - 1 Jan 1992

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this